[ Price : $8.95]
FDA approves an AstraZeneca NDA for Truqap (capivasertib) for use with fulvestrant in certain adult patients with hormone receptor...[ Price : $8.95]
FDA approves a Merck NDA for Keytruda (pembrolizumab) and its use with fluoropyrimidine- and platinum-containing chemotherapy for ...[ Price : $8.95]
Asensus Surgical recalls its Senhance Surgical System due to malfunctions that cause unintended movement of the robotically assist...[ Price : $8.95]
Braun Medical recalls its Infusomat Space Volumetric Infusion Pump System due to faulty occlusion alarms.[ Price : $8.95]
FDA approves Astellas Pharmas Xtandi (enzalutamide) for an expanded use treating non-metastatic castration-sensitive prostate can...[ Price : $8.95]
Federal Register notice: FDA corrects a notice that appeared in the 7/8/2022 Federal Register that announced an agency determinati...[ Price : $8.95]
Federal Register notice: FDA announces a 2/2/2024 advisory committee meeting to discuss pulse oximeter quality.[ Price : $8.95]
FDA issues one final and one draft guidance related to Section 506J notifications of medical device shortages.